Medicine & Life Sciences
Pancreatic Neoplasms
100%
Breast Neoplasms
81%
Neoplasms
74%
Patient Reported Outcome Measures
67%
Cancer Survivors
62%
Survival
57%
Adenocarcinoma
51%
Survivorship
51%
Prostatic Neoplasms
46%
Acute Myeloid Leukemia
45%
Survivors
40%
Aromatase Inhibitors
34%
Mutation
32%
Therapeutics
31%
Confidence Intervals
30%
Genes
28%
Prostate-Specific Antigen
21%
Preventive Medicine
21%
Methylation
21%
alvocidib
20%
Colorectal Neoplasms
20%
Cytarabine
20%
Drug Therapy
20%
N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine
20%
Randomized Controlled Trials
19%
Accidental Falls
19%
Vitamin D
18%
Leukemia
18%
Quality of Life
18%
Primary Health Care
18%
Progression-Free Survival
17%
Epidemiology
17%
Chronic Obstructive Pulmonary Disease
17%
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
17%
Incidence
17%
Early Detection of Cancer
17%
Mitoxantrone
17%
Medicare
17%
Comorbidity
16%
Induction Chemotherapy
16%
Recurrence
16%
Pituitary Dwarfism
16%
Odds Ratio
15%
Bone Marrow
15%
Pancreatic Cyst
15%
Elderly
14%
Oncologists
14%
25-hydroxyvitamin D
14%
Castration
14%
Telomere
14%